Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C2 | P08235 | 2/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.34 |
| ▸ | CASP3 | P42574 | 1/20 | 0.32 |
| ▸ | CASP7 | P55210 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | GRM1 | Q13255 | 3/20 | 0.31 |
| ▸ | GRM4 | Q14833 | 2/20 | 0.31 |
| ▸ | PARK7 | Q99497 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 2/20 | 0.31 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.30 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.30 |
| ▸ | GRM7 | Q14831 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20693054 | 0.96 | NR3C2 (0.39) | NR3C2ESR1ESR2CASP3CASP7 | |
| SCHEMBL22039636 | 0.91 | MAOA (0.39) | NR3C2CASP3ALDH1A1GAAGRM1 | |
| SCHEMBL22039637 | 0.90 | GRM1 (0.40) | NR3C2ESR1ESR2GRM1GRM4 | |
| SCHEMBL20693118 | 0.90 | ESR1 (0.47) | NR3C2ESR1ESR2ALDH1A1GAA | |
| SCHEMBL30799095 | 0.89 | NR3C2 (0.37) | NR3C2ESR1ESR2GRM1GRM4 | |
| SCHEMBL21990702 | 0.89 | NR3C2 (0.37) | NR3C2ESR1ESR2GRM1GRM4 | |
| SCHEMBL903301 | 0.89 | ESR1 (0.36) | ESR1ESR2CASP3CASP7GRM1 | |
| SCHEMBL20693122 | 0.88 | NR3C2 (0.39) | NR3C2ESR1ESR2GRM1GRM4 | |
| SCHEMBL20693107 | 0.88 | ALDH1A1 (0.39) | NR3C2ESR1ALDH1A1 | |
| SCHEMBL20693099 | 0.85 | NR3C2 (0.38) | NR3C2ESR1ESR2PARK7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3658551-B1 | BENZOXAZINONE DERIVATIVES USEFUL AS HERBICIDES | REDAG CROP PROT LTD (GB) | 2022-01-19 | — | — | EP | disclosed |
| US-20200172527-A1 | BENZOXAZINONE DERIVATIVES USEFUL AS HERBICIDES | REDAG CROP PROT LTD (GB) | 2020-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200172527-A1 | BENZOXAZINONE DERIVATIVES USEFUL AS HERBICIDES | CBR3, CBR1, CYP4X1 | NR3C2 450/4885ESR1 973/4885ESR2 823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.